Skip to main content
Clinical Trials/EUCTR2016-001528-69-IE
EUCTR2016-001528-69-IE
Active, not recruiting
Phase 1

PENICILLIN FOR THE EMERGENCY DEPARTMENT-DIRECTED OUTPATIENT TREATMENT OF CELLULITIS (PEDOCELL) STUDY: A NON-INFERIORITY ADAPTIVE RANDOMISED CONTROLLED TRIAL.

Royal College of Surgeons in Ireland0 sites50 target enrollmentAugust 10, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Skin Infection
Sponsor
Royal College of Surgeons in Ireland
Enrollment
50
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Clinically diagnosed cellulitis, wound infection \& abscess affecting any body part, excluding the perineum, and having any two of the following signs:
  • Tenderness / Pain of affected area
  • Oedema / Induration
  • Regional lymphadenopathy
  • Purulent drainage
  • 2\.Cellulitis, wound infection \& abscess deemed treatable with oral antibiotics on an outpatient basis
  • 3\.Patients with cellulitis, wound infection \& abscess who have no signs of systemic toxicity and have no uncontrolled co\-morbidities.
  • 4\.Written informed consent obtained.
  • 5\.16 years of age or older.
  • 6\.Fluency in written and spoken English.

Exclusion Criteria

  • 1\.Penicillin allergy (self\-reported or confirmed).
  • 2\.Any cellulitis wound infection \& abscess that treating clinicians deem treatable with intravenous (IV) antibiotics.
  • 3\.Patients that may have a significant systemic upset such as acute confusion, tachycardia, tachypnoea, hypotension or may have unstable co\-morbidities that may interfere with a response to therapy or have a limb threatening infection due to vascular compromise.
  • 4\.Patients who may have a severe life threatening infection such as necrotizing fasciitis.
  • 5\.Any cellulitis wound infection \& abscess of the perineal region.
  • 6\.Patients who have received more than 24 hours of effective antibiotics for the current episode of acute cellulitis, wound infection \& abscess
  • 7\.Any medical condition, based on clinical judgment that may interfere with the interpretation of the primary outcome measures (e.g. a chronic skin condition at the site of the cellulitis wound infection or abscess).
  • 8\.Immunodeficiency from primary or secondary causes (e.g. corticosteroids, chemotherapeutic agents).
  • 9\.Previous history of renal dysfunction or known chronic kidney disease under the care of a nephrologist. ?
  • 10\.Previous history of liver dysfunction defined as chronically deranged liver function tests elicited from the medical notes or history.

Outcomes

Primary Outcomes

Not specified

Similar Trials